Cover Image

Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC

BackgroundHepatocellular carcinoma (HCC) is the most common primary liver cancer and often arises in the context of chronic liver disease, such as hepatitis B or C infection, and cirrhosis. Advanced unresectable HCC (uHCC) presents significant treatment challenges due to its advanced stage and inope...

Full description

Saved in:

Bibliographic Details
Main Authors:	Li-xin Du (Author), Guo-li Sheng (Author), An-da Shi (Author), Kang-shuai Li (Author), Zeng-li Liu (Author), Yong-chang Tang (Author), Yi Liu (Author), Zong-li Zhang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma
by: Kang-shuai Li, et al.
Published: (2024)

Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis
by: Miaomiao Yang, et al.
Published: (2024)

Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization
by: Li Q, et al.
Published: (2018)

Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer
by: Guo D, et al.
Published: (2021)

Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report
by: In-Jung Kim, et al.
Published: (2022)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020)

Clinical Efficacy and Safety of an Immune Checkpoint Inhibitor in Combination with Regorafenib Therapy as Second-Line Regimen for Patients with Unresectable Hepatocellular Carcinoma
by: Li J, et al.
Published: (2023)

Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
by: Ye Peng, et al.
Published: (2022)

Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy
by: Jiazhao Song, et al.
Published: (2023)

A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics
by: Menghan Zhang, et al.
Published: (2024)

Clinical presentation of perineal endometriosis and prognostic nomogram after surgical resection
by: Shiyang Zhu, et al.
Published: (2022)

Correction: Clinical presentation of perineal endometriosis and prognostic nomogram after surgical resection
by: Shiyang Zhu, et al.
Published: (2022)

Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma
by: Sayuri Yoshikawa, et al.
Published: (2023)

A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
by: Yaoting Li, et al.
Published: (2023)

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
by: Hsin-Yu Kuo, et al.
Published: (2022)

Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients
by: Guangsheng Zhao, et al.
Published: (2021)

Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
by: Yonghua Bi, et al.
Published: (2022)

Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma
by: Hironao Okubo, et al.
Published: (2022)

Cost-effectiveness analysis of sintilimab plus bevacizumab biosimilar compared with lenvatinib as the first-line treatment of unresectable or metastatic hepatocellular carcinoma
by: Ting Zhou, et al.
Published: (2022)

Prediction of minimal hepatic encephalopathy by using an radiomics nomogram in chronic hepatic schistosomiasis patients.
by: Ying Li, et al.
Published: (2021)

Immune Checkpoint Inhibitors Plus an Anti-VEGF Antibody as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis
by: Lu Li, et al.
Published: (2022)

The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy
by: Topkan E, et al.
Published: (2021)

Analysis of the absorbed constituents and mechanism of liquidambaris fructus extract on hepatocellular carcinoma
by: Shuai Wang, et al.
Published: (2022)

A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma
by: Jun Liu, et al.
Published: (2021)

Prognostic value and immune infiltration analyses of cuproptosis-related genes in hepatocellular carcinoma
by: Junjie Li, et al.
Published: (2023)

Therapeutic efficacy and safety of Compound Kushen Injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An update systematic review and meta-analysis
by: Xiao eMa, et al.
Published: (2016)

Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate
by: Wei Li, et al.
Published: (2024)

Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary
by: Huijie Wu, et al.
Published: (2021)

Development and Validation of a Prognostic Nomogram to Predict 30-Day Mortality Risk in Patients with Sepsis-Induced Cardiorenal Syndrome
by: Yiguo Liu, et al.
Published: (2022)

Complement 3 and the Prognostic Nutritional Index Distinguish Kawasaki Disease from Other Fever Illness with a Nomogram
by: Yi-Shuang Huang, et al.
Published: (2021)

Comprehensive Analysis of NABP2 as a Prognostic Biomarker and Its Correlation with Immune Infiltration in Hepatocellular Carcinoma
by: Li B, et al.
Published: (2023)

TACE-Sorafenib With Thermal Ablation Has Survival Benefits in Patients With Huge Unresectable Hepatocellular Carcinoma
by: Ying Wu, et al.
Published: (2020)

Changes in Serum Interleukin-8 Levels Predict Response to Immune Checkpoint Inhibitors Immunotherapy in Unresectable Hepatocellular Carcinoma Patients
by: Zhang J, et al.
Published: (2024)

Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis
by: Zheng Li, et al.
Published: (2021)

The development of Teacher Academic Emotions (TAE) Scale
by: Masoud Geramipour, et al.
Published: (2019)

Tae kwon-do, o karatê coreano
by: Marco Aurélio Araújo Texeira
Published: (1977)

A preliminary study on drug switching strategy for second-line therapy after combination treatment of tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
by: Renguo Guan, et al.
Published: (2022)

OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma
by: Yang An, et al.
Published: (2020)

Analysis of prognostic factors for cervical mucinous adenocarcinoma and establishment and validation a nomogram: a SEER-based study
by: Yiping Hao, et al.
Published: (2023)

Development and Validation of an Inflammation-Combined Prognostic Index (ICPI)-Based Nomogram for Predicting Overall Survival in Gastric Cancer
by: Li X, et al.
Published: (2024)